Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
GPT Healthcare Limited (GPTHEALTH.NS)
Kolkata, IN
GPT Healthcare Limited runs a network of multispecialty hospitals across India under the ILS Hospitals brand. The company provides an extensive array of medical services, encompassing internal medicine, diabetology, and specialized nephrology procedures like renal transplants. Its offerings also include various laparoscopic and general surgeries, gynecology and obstetrics, critical care, gastroenterology, orthopedics with joint replacement, interventional cardiology, neurosciences, pediatrics, diagnostic facilities, and neonatology. Furthermore, the company manages its own pharmacies. Established in 1989, GPT Healthcare Limited is headquartered in Kolkata, India, and operates as a subsidiary of GPT Sons Pvt. Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.42% | +0.58% | +2.99% | +14.24% | -0.91% | -0.14% | -8.52% | -30.21% | -30.21% | -30.21% | -30.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+13.7% ★ Q1'26: +22.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-15.3% Q1'26: +13.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+8.8% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+12.1% ★ Q1'26: +13.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+14.0% ★ Q1'26: +19.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.2% ★ Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.08× ★ Q1'26: 0.98× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
4.16B
est: 4.19B (-0.7%)
|
4.68B
4.68B – 4.68B
+11.9% YoY
|
5.58B
5.58B – 5.58B
+19.0% YoY
|
6.44B
6.44B – 6.44B
+15.6% YoY
|
| EBITDA |
918.47M
est: 905.33M (+1.5%)
|
1.01B
1.01B – 1.01B
+11.9% YoY
|
1.21B
1.21B – 1.21B
+19.0% YoY
|
1.39B
1.39B – 1.39B
+15.6% YoY
|
| EBIT |
728.17M
est: 713.00M (+2.1%)
|
798.02M
798.02M – 798.02M
+11.9% YoY
|
949.82M
949.82M – 949.82M
+19.0% YoY
|
1.10B
1.10B – 1.10B
+15.6% YoY
|
| Net Income |
499.22M
est: 532.88M (-6.3%)
|
377.12M
377.12M – 377.12M
-29.2% YoY
|
631.26M
631.26M – 631.26M
+67.4% YoY
|
819.82M
819.82M – 819.82M
+29.9% YoY
|
| SGA |
121.16M
est: 859.10M (-85.9%)
|
961.53M
961.53M – 961.53M
+11.9% YoY
|
1.14B
1.14B – 1.14B
+19.0% YoY
|
1.32B
1.32B – 1.32B
+15.6% YoY
|
| EPS |
6.08
est: 6.50 (-6.5%)
|
4.60
4.60 – 4.60
-29.2% YoY
|
7.70
7.70 – 7.70
+67.4% YoY
|
10.00
10.00 – 10.00
+29.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 64.8K | 0.33% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Om Prakash Tantia | Chairman & MD | 29M | — |
| Anurag Tantia | Executive Director | 16M | male |
| Ankur Sharma | Company Secretary & Compliance Officer | 1M | male |
| Mohua Golder | Chief Operating Officer of Administration Department - ILS Hospital | — | — |
| Debashis Dhar | Senior Vice President & Chief Business Development Officer | — | male |
| Sanjay Kant Mishra | Chief Operating Officer of ILS Salt Lake Hospital | — | — |
| Tirthankar Bagchi | Chief Operating Officer of ILS Hospital in Dum Dum, West Bengal | — | — |
| Vishal Goyal | Group Chief Operating Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GPTHEALTH.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
